Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Adaptive decision making in a lymphocyte infusion trial.

Thall PF, Inoue LY, Martin TG.

Biometrics. 2002 Sep;58(3):560-8.

PMID:
12229990
[PubMed - indexed for MEDLINE]
3.

Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.

Dey BR, McAfee S, Colby C, Sackstein R, Saidman S, Tarbell N, Sachs DH, Sykes M, Spitzer TR.

Biol Blood Marrow Transplant. 2003 May;9(5):320-9.

PMID:
12766882
[PubMed - indexed for MEDLINE]
4.

Donor lymphocyte infusion. An adaptive cellular immunotherapy for treatment of hematological malignancies.

Owaidah TM.

Saudi Med J. 2003 Feb;24(2):138-41. Review.

PMID:
12682675
[PubMed - indexed for MEDLINE]
5.

Dose-finding based on feasibility and toxicity in T-cell infusion trials.

Thall PF, Sung HG, Choudhury A.

Biometrics. 2001 Sep;57(3):914-21.

PMID:
11550945
[PubMed - indexed for MEDLINE]
6.

Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy--from bench to patient bedside.

Slavin S, Morecki S, Weiss L, Shapira MY, Resnick I, Or R.

Semin Oncol. 2004 Feb;31(1):4-21. Review.

PMID:
14970932
[PubMed - indexed for MEDLINE]
7.

Determining a maximum-tolerated schedule of a cytotoxic agent.

Braun TM, Yuan Z, Thall PF.

Biometrics. 2005 Jun;61(2):335-43.

PMID:
16011679
[PubMed - indexed for MEDLINE]
8.

[A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].

Chen Y, Huang X, Xu L, Liu D, Zhang Y, Ren H, Guo N, Lu D.

Zhonghua Yi Xue Za Zhi. 2002 Oct 10;82(19):1306-9. Chinese.

PMID:
12509932
[PubMed - indexed for MEDLINE]
9.

Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.

Joshi SS, Bishop MR, Lynch JC, Tarantolo SR, Abhyankar S, Bierman PJ, Vose JM, Geller RB, McGuirk J, Foran J, Bociek RG, Hadi A, Day SD, Armitage JO, Kessinger A, Pavletic ZS.

Cytotherapy. 2003;5(6):542-52.

PMID:
14660050
[PubMed - indexed for MEDLINE]
10.

[Treatment of malignant hematologic diseases by peripheral blood stem cell transplantation combined with halotype lymphocyte infusion].

Wu BY, Song CY, Guo KY, Yan DA, Yang YL, Xiao LL, Wu GX.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Jun;11(3):287-91. Chinese.

PMID:
12844415
[PubMed - indexed for MEDLINE]
11.

Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology.

Brannath W, Zuber E, Branson M, Bretz F, Gallo P, Posch M, Racine-Poon A.

Stat Med. 2009 May 1;28(10):1445-63. doi: 10.1002/sim.3559.

PMID:
19266565
[PubMed - indexed for MEDLINE]
12.

Diverse clinical applications using advantages of allogeneic peripheral blood stem cell transplantation.

Sohn SK, Kim JG, Kim DH, Baek JH, Lee KB.

Int J Hematol. 2004 Jun;79(5):457-61. Review.

PMID:
15239395
[PubMed - indexed for MEDLINE]
13.

Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed.

Fung HC, Cohen S, Rodriguez R, Smith D, Krishnan A, Somlo G, Sahebi F, Senitzer D, O'Donnell MR, Stein A, Snyder DS, Spielberger R, Bhatia R, Falk P, Molina A, Nademanee A, Parker P, Kogut N, Popplewell L, Vora N, Margolin K, Forman SJ.

Biol Blood Marrow Transplant. 2003 Oct;9(10):649-56.

PMID:
14569561
[PubMed - indexed for MEDLINE]
14.

Anti-T-lymphocyte globulin based non-myeloablative stem cell transplantation followed by HLA-identical donor lymphocyte infusion for hematologic malignancies.

Mao P, Wang S, Wang H, Li Q, Xu Y, Mo W, Ying Y, Zhu Z.

Chin Med J (Engl). 2003 Jan;116(1):70-3.

PMID:
12667392
[PubMed - indexed for MEDLINE]
15.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

PMID:
12869717
[PubMed - indexed for MEDLINE]
Free Article
16.

Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.

Lee CK, deMagalhaes-Silverman M, Hohl RJ, Hayashi M, Buatti J, Wen BC, Schlueter A, Strauss RG, Gingrich RD.

Bone Marrow Transplant. 2003 Jan;31(2):121-8.

PMID:
12621494
[PubMed - indexed for MEDLINE]
17.

Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors.

Barge RM, Osanto S, Marijt WA, Starrenburg CW, Fibbe WE, Nortier JW, Falkenburg JH, Willemze R.

Exp Hematol. 2003 Oct;31(10):865-72.

PMID:
14550801
[PubMed - indexed for MEDLINE]
18.

Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning.

Kobbe G, Schneider P, Aivado M, Zohren F, Schubert D, Fenk R, Neumann F, Kronenwett R, Pape H, Rong A, Royer-Pokora B, Hildebrandt B, Germing U, Gattermann N, Heyll A, Haas R.

Exp Hematol. 2002 Nov;30(11):1346-53.

PMID:
12423689
[PubMed - indexed for MEDLINE]
19.

A Bayesian approach to jointly modeling toxicity and biomarker expression in a phase I/II dose-finding trial.

Bekele BN, Shen Y.

Biometrics. 2005 Jun;61(2):343-54.

PMID:
16011680
[PubMed - indexed for MEDLINE]
20.

Using joint utilities of the times to response and toxicity to adaptively optimize schedule-dose regimes.

Thall PF, Nguyen HQ, Braun TM, Qazilbash MH.

Biometrics. 2013 Sep;69(3):673-82. doi: 10.1111/biom.12065. Epub 2013 Aug 19.

PMID:
23957592
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk